Cargando…

LLGL2 Increases Ca(2+) Influx and Exerts Oncogenic Activities via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma

BACKGROUND: Lethal giant larvae (Lgl), scaffolding proteins, regulate the epithelial cell apicobasal polarity in Drosophila. They play important roles in asymmetric cell division, cell migration, and progenitor cells self-renewal as tumor suppressors. One of Lgl mammalian homologues proteins, LLGL2...

Descripción completa

Detalles Bibliográficos
Autores principales: Leng, Shusheng, Xie, Fei, Liu, Junyi, Shen, Junyi, Quan, Guangqian, Wen, Tianfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223678/
https://www.ncbi.nlm.nih.gov/pubmed/34178676
http://dx.doi.org/10.3389/fonc.2021.683629
_version_ 1783711741941645312
author Leng, Shusheng
Xie, Fei
Liu, Junyi
Shen, Junyi
Quan, Guangqian
Wen, Tianfu
author_facet Leng, Shusheng
Xie, Fei
Liu, Junyi
Shen, Junyi
Quan, Guangqian
Wen, Tianfu
author_sort Leng, Shusheng
collection PubMed
description BACKGROUND: Lethal giant larvae (Lgl), scaffolding proteins, regulate the epithelial cell apicobasal polarity in Drosophila. They play important roles in asymmetric cell division, cell migration, and progenitor cells self-renewal as tumor suppressors. One of Lgl mammalian homologues proteins, LLGL2 overexpression has been reported in ER+ breast cancer and promotes tumor proliferation through regulating leucine uptake. Nonetheless, the role of LLGL2 in hepatocellular carcinoma (HCC) is still unknown. METHODS: TCGA dataset mining, qRT-PCR, Western blot along with immunohistochemistry assays were employed to explore LLGL2 expression in human HCC samples and cell lines. Moreover, the clinical value of LLGL2 was investigated in 156 HCC patients. Furthermore, the role as well as the molecular mechanism of LLGL2 in the progression of HCC was explored through a series of in vitro and in vivo experiments. RESULTS: LLGL2 was up-regulated in HCC tissues, which was related with certain clinicopathological features including tumor number, vascular invasion as well as advanced stage. High expression of LLGL2 predicted poor prognosis after hepatectomy. LLGL2 promoted HCC cells proliferation, migration and invasion through PI3K/ATK signaling by promoting calcium ion influx. CONCLUSION: Our study identified that LLGL2 is a tumor promoter in HCC for the first time, which could potentially be utilized as a new biomarker and a therapeutic target for HCC.
format Online
Article
Text
id pubmed-8223678
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82236782021-06-25 LLGL2 Increases Ca(2+) Influx and Exerts Oncogenic Activities via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma Leng, Shusheng Xie, Fei Liu, Junyi Shen, Junyi Quan, Guangqian Wen, Tianfu Front Oncol Oncology BACKGROUND: Lethal giant larvae (Lgl), scaffolding proteins, regulate the epithelial cell apicobasal polarity in Drosophila. They play important roles in asymmetric cell division, cell migration, and progenitor cells self-renewal as tumor suppressors. One of Lgl mammalian homologues proteins, LLGL2 overexpression has been reported in ER+ breast cancer and promotes tumor proliferation through regulating leucine uptake. Nonetheless, the role of LLGL2 in hepatocellular carcinoma (HCC) is still unknown. METHODS: TCGA dataset mining, qRT-PCR, Western blot along with immunohistochemistry assays were employed to explore LLGL2 expression in human HCC samples and cell lines. Moreover, the clinical value of LLGL2 was investigated in 156 HCC patients. Furthermore, the role as well as the molecular mechanism of LLGL2 in the progression of HCC was explored through a series of in vitro and in vivo experiments. RESULTS: LLGL2 was up-regulated in HCC tissues, which was related with certain clinicopathological features including tumor number, vascular invasion as well as advanced stage. High expression of LLGL2 predicted poor prognosis after hepatectomy. LLGL2 promoted HCC cells proliferation, migration and invasion through PI3K/ATK signaling by promoting calcium ion influx. CONCLUSION: Our study identified that LLGL2 is a tumor promoter in HCC for the first time, which could potentially be utilized as a new biomarker and a therapeutic target for HCC. Frontiers Media S.A. 2021-06-10 /pmc/articles/PMC8223678/ /pubmed/34178676 http://dx.doi.org/10.3389/fonc.2021.683629 Text en Copyright © 2021 Leng, Xie, Liu, Shen, Quan and Wen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Leng, Shusheng
Xie, Fei
Liu, Junyi
Shen, Junyi
Quan, Guangqian
Wen, Tianfu
LLGL2 Increases Ca(2+) Influx and Exerts Oncogenic Activities via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma
title LLGL2 Increases Ca(2+) Influx and Exerts Oncogenic Activities via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma
title_full LLGL2 Increases Ca(2+) Influx and Exerts Oncogenic Activities via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma
title_fullStr LLGL2 Increases Ca(2+) Influx and Exerts Oncogenic Activities via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma
title_full_unstemmed LLGL2 Increases Ca(2+) Influx and Exerts Oncogenic Activities via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma
title_short LLGL2 Increases Ca(2+) Influx and Exerts Oncogenic Activities via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma
title_sort llgl2 increases ca(2+) influx and exerts oncogenic activities via pi3k/akt signaling pathway in hepatocellular carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223678/
https://www.ncbi.nlm.nih.gov/pubmed/34178676
http://dx.doi.org/10.3389/fonc.2021.683629
work_keys_str_mv AT lengshusheng llgl2increasesca2influxandexertsoncogenicactivitiesviapi3kaktsignalingpathwayinhepatocellularcarcinoma
AT xiefei llgl2increasesca2influxandexertsoncogenicactivitiesviapi3kaktsignalingpathwayinhepatocellularcarcinoma
AT liujunyi llgl2increasesca2influxandexertsoncogenicactivitiesviapi3kaktsignalingpathwayinhepatocellularcarcinoma
AT shenjunyi llgl2increasesca2influxandexertsoncogenicactivitiesviapi3kaktsignalingpathwayinhepatocellularcarcinoma
AT quanguangqian llgl2increasesca2influxandexertsoncogenicactivitiesviapi3kaktsignalingpathwayinhepatocellularcarcinoma
AT wentianfu llgl2increasesca2influxandexertsoncogenicactivitiesviapi3kaktsignalingpathwayinhepatocellularcarcinoma